Molecular and Genetic Analysis of Lung Cancer

Purpose

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Condition

  • Lung Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy controls: participants without evidence of any cancer - cases: pathology proven primary lung cancer

Exclusion Criteria

  • younger than 18 years old

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Andrea Shafer, MPH
6177269274

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

David Christiani, MD
617-726-9274
dchris@hsph.harvard.edu

Detailed Description

Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.